Compounds like Forskolin, PMA, and Ionomycin are known to modulate key cellular signaling pathways through cAMP elevation, PKC activation, and calcium signaling, respectively. If C12orf45 is involved in these pathways, these compounds could enhance its activity by creating an environment conducive to its functional role.
Additionally, broad-spectrum inhibitors like Staurosporine and metabolic pathway modulators like 2-Deoxy-D-glucose provide insights into how the modulation of general cellular processes might impact C12orf45 activity.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates protein kinase C (PKC), potentially influencing pathways that C12orf45 may be part of, thereby modulating its activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin increases intracellular calcium levels, which can modulate various signaling pathways and might indirectly enhance C12orf45 activity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Staurosporine, a broad-spectrum kinase inhibitor, could impact various signaling pathways and potentially modulate C12orf45 activity. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $65.00 $210.00 | 26 | |
2-Deoxy-D-glucose interferes with glycolysis. If C12orf45 is involved in metabolic pathways, this compound could indirectly affect its activity. |